Despite the overexpression of DNAM-1 ligand (CD112 or CD155) on human primary sarcoma cells, a preclinical study observed that NK cells minimally infiltrated into sarcomas and tended to downregulate the expression of activating receptors DNAM-1 and NKG2D [181]. The gene discussed is NECTIN2; the disease is sarcoma.